Trial for Evaluation of Safety of Escalating Dose Levels of MEDI-507 in Patients for Treatment of at Least Grade II Graft-Versus-Host Disease (GvHD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1999
A trial to assess safety of four doses of MEDI 507 combined with another drug for initial treatment of at least Grade II acute Graft-vs-Host Disease in recipients.
Epistemonikos ID: f3f20dc266995c9addc3ee40014b9d05e74997e1
First added on: May 05, 2024